Paragonix Technologies SherpaPak® Improves 1-Year Survival in Heart Transplant Patients in Real-World Study

GUARDIAN Registry data presented at ISHLT 2022 has shown a 72% reduction (p=0.005) in Severe PGD (primary graft dysfunction) and a 39% reduction (p=0.03) in Mechanical Circulatory Support, in addition…

Continue ReadingParagonix Technologies SherpaPak® Improves 1-Year Survival in Heart Transplant Patients in Real-World Study

Paragonix Technologies Hosting ISHLT Industry Symposium “Improving Transplant Outcomes with Advanced Donor Heart Preservation & Transport”

Paragonix medical devices featured in multiple seminars and posters at Boston’s ISHLT 2022 Annual Meeting outcomes CAMBRIDGE, MASSACHUSETTS – Paragonix Technologies, Inc., a leading organ preservation provider, is presenting new research…

Continue ReadingParagonix Technologies Hosting ISHLT Industry Symposium “Improving Transplant Outcomes with Advanced Donor Heart Preservation & Transport”